Age-related differences in white matter integrity and cognitive function are related to APOE status

While an extensive literature is now available on age-related differences in white matter integrity measured by diffusion MRI, relatively little is known about the relationships between diffusion and cognitive functions in older adults. Even less is known about whether these relationships are influenced by the apolipoprotein (APOE) ε4 allele, despite growing evidence that ε4 increases cognitive impairment in older adults. The purpose of the present study was to examine these relationships in a group of community-dwelling cognitively normal older adults. Data were obtained from a sample of 126 individuals (ages 52-92) that included 32 ε4 heterozygotes, 6 ε4 homozygotes, and 88 noncarriers. Two measures of diffusion, the apparent diffusion coefficient (ADC) and fractional anisotropy (FA), were obtained from six brain regions-frontal white matter, lateral parietal white matter, the centrum semiovale, the genu and splenium of the corpus callosum, and the temporal stem white matter-and were used to predict composite scores of cognitive function in two domains, executive function and memory function. Results indicated that ADC and FA differed with increasing age in all six brain regions, and these differences were significantly greater for ε4 carriers compared to noncarriers. Importantly, after controlling for age, diffusion measures predicted cognitive function in a region-specific way that was also influenced by ε4 status. Regardless of APOE status, frontal ADC and FA independently predicted executive function scores for all participants, while temporal lobe ADC additionally predicted executive function for ε4 carriers but not noncarriers. Memory scores were predicted by temporal lobe ADC but not frontal diffusion for all participants, and this relationship was significantly stronger in ε4 carriers compared to noncarriers. Taken together, age and temporal lobe ADC accounted for a striking 53% of the variance in memory scores within the ε4 carrier group. The results provide further evidence that APOE ε4 has a significant impact on the trajectory of age-related cognitive functioning in older adults. Possible mechanisms are discussed that could account for the associations between ε4, diffusion, and cognitive function, including the influence of ε4 on neural repair, oxidative stress, and the health of myelin-producing oligodendroglia.

[1]  Osamu Abe,et al.  Aging in the CNS: Comparison of gray/white matter volume and diffusion tensor data , 2008, Neurobiology of Aging.

[2]  Maximilian Reiser,et al.  Multivariate network analysis of fiber tract integrity in Alzheimer’s disease , 2007, NeuroImage.

[3]  Manjit,et al.  Neurology , 1912, NeuroImage.

[4]  Ke-Min Chen,et al.  Diffusion Tensor Imaging Correlates with Proton Magnetic Resonance Spectroscopy in Posterior Cingulate Region of Patients with Alzheimer’s Disease , 2008, Dementia and Geriatric Cognitive Disorders.

[5]  G. Bartzokis.  Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease , 2004, Neurobiology of Aging.

[6]  C. Oppenheim,et al.  Diffusion tensor imaging in early Alzheimer's disease , 2006, Psychiatry Research: Neuroimaging.

[7]  B. Reisberg,et al.  Diffusion Tensor Imaging of Frontal White Matter Microstructure in Early Alzheimer’s Disease: A Preliminary Study , 2005, Journal of geriatric psychiatry and neurology.

[8]  Nicolas Cherbuin,et al.  Neuroimaging and APOE Genotype: A Systematic Qualitative Review , 2007, Dementia and Geriatric Cognitive Disorders.

[9]  Andrew J. Saykin,et al.  Regional brain atrophy in cognitively intact adults with a single APOE ε4 allele , 2006, Neurology.

[10]  L. White,et al.  Adult age differences in the functional neuroanatomy of visual attention: A combined fMRI and DTI study , 2007, Neurobiology of Aging.

[11]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[12]  C. Lines,et al.  Rofecoxib , 2004, Neurology.

[13]  G. Alexander,et al.  Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism , 2005 .

[14]  M. Szklo,et al.  Atherosclerosis Risk in Communities (ARIC) Study Neighbourhood differences in diet: the , 2007 .

[15]  N. Raz,et al.  Aging white matter and cognition: Differential effects of regional variations in diffusion properties on memory, executive functions, and speed , 2009, Neuropsychologia.

[16]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[17]  T. Trouard,et al.  Anti-inflammatory drugs reduce age-related decreases in brain volume in cognitively normal older adults , 2011, Neurobiology of Aging.

[18]  M. O’Sullivan,et al.  White matter damage on diffusion tensor imaging correlates with age-related cognitive decline , 2006, Neurology.

[19]  G. Schellenberg,et al.  Apolipoprotein E genotype and memory in the sixth decade of life , 2008, Neurology.

[20]  Arthur MacNeill Horton,et al.  Wechsler Memory Scale III , 1999 .

[21]  Wang Zhan,et al.  Patterns of age-related water diffusion changes in human brain by concordance and discordance analysis , 2010, Neurobiology of Aging.

[22]  S. Schoenberg,et al.  White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. , 2007, Radiology.

[23]  L. Baxter,et al.  Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele , 2004, Neurology.

[24]  Lars-Göran Nilsson,et al.  The influence of APOE status on episodic and semantic memory: data from a population-based study. , 2006, Neuropsychology.

[25]  E. Gordon,et al.  Cognitive aging, executive function, and fractional anisotropy: a diffusion tensor MR imaging study. , 2007, AJNR. American journal of neuroradiology.

[26]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[27]  I. Deary,et al.  Childhood and current cognitive function in healthy 80-year-olds: a DT-MRI study , 2003, Neuroreport.

[28]  Carole Dufouil,et al.  No ɛ4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects , 2005, NeuroImage.

[29]  Scott A. Huettel,et al.  Age-related slowing of memory retrieval: Contributions of perceptual speed and cerebral white matter integrity , 2008, Neurobiology of Aging.

[30]  Paul M. Thompson,et al.  Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers , 2008, NeuroImage.

[31]  L Nyberg,et al.  Altered brain white matter integrity in healthy carriers of the APOE ε4 allele , 2006, Neurology.

[32]  A. Dale,et al.  Age-related alterations in white matter microstructure measured by diffusion tensor imaging , 2005, Neurobiology of Aging.

[33]  Lars Bäckman,et al.  Apolipoprotein E and cognitive performance: a meta-analysis. , 2004, Psychology and aging.

[34]  Christina N. Lessov-Schlaggar,et al.  Apolipoprotein E ε4 and Change in Cognitive Functioning in Community-Dwelling Older Adults , 2005 .

[35]  D. Delis,et al.  The California verbal learning test , 2016 .

[36]  Jelle Jolles,et al.  Multiple indicators of age-related differences in cerebral white matter and the modifying effects of hypertension , 2010, NeuroImage.

[37]  Sterling C. Johnson,et al.  White matter is altered with parental family history of Alzheimer's disease , 2010, Alzheimer's & Dementia.

[38]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[39]  G. Schellenberg,et al.  Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults. , 2005, Journal of geriatric psychiatry and neurology.

[40]  J. Mazziotta,et al.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Wesson Ashford,et al.  Apolipoprotein E ɛ4 influences on episodic recall and brain structures in aging pilots , 2010, Neurobiology of Aging.

[42]  Y. Zang,et al.  Voxel-based detection of white matter abnormalities in mild Alzheimer disease , 2006, Neurology.

[43]  Matthias J. Müller,et al.  Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment , 2005, Neurobiology of Aging.

[44]  H. Hanyu,et al.  Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease , 1998, Journal of the Neurological Sciences.

[45]  Šimon Scharf,et al.  A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease , 1999, Neurology.

[46]  M. Etminan,et al.  Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies , 2003, BMJ : British Medical Journal.

[47]  R. Kraft,et al.  Relating imaging indices of white matter integrity and volume in healthy older adults. , 2008, Cerebral cortex.

[48]  Scott A. Huettel,et al.  Diffusion tensor imaging of adult age differences in cerebral white matter: relation to response time , 2004, NeuroImage.

[49]  T. Q. Irigaray,et al.  Intellectual abilities in Alzheimer's disease patients: Contributions from the Wechsler Abbreviated Scale of Intelligence (WASI) , 2010 .

[50]  Gerald Rimbach,et al.  Impact of apoE genotype on oxidative stress, inflammation and disease risk. , 2008, Molecular nutrition & food research.

[51]  Kewei Chen,et al.  Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[52]  P. Aisen,et al.  Randomized pilot study of nimesulide treatment in Alzheimer’s disease , 2002, Neurology.

[53]  I. Deary,et al.  Cognitive Correlates of Cerebral White Matter Lesions and Water Diffusion Tensor Parameters in Community-Dwelling Older People , 2005, Cerebrovascular Diseases.

[54]  Kimberly M Ray,et al.  Mild cognitive impairment: apparent diffusion coefficient in regional gray matter and white matter structures. , 2006, Radiology.

[55]  A. Pfefferbaum,et al.  Selective age-related degradation of anterior callosal fiber bundles quantified in vivo with fiber tracking. , 2006, Cerebral cortex.

[56]  John Russell,et al.  Dysmyelination Revealed through MRI as Increased Radial (but Unchanged Axial) Diffusion of Water , 2002, NeuroImage.

[57]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[58]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[59]  G. Alexander,et al.  Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Eric M Reiman,et al.  Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. , 2007, Archives of neurology.

[61]  Jung-Lung Hsu,et al.  Gender differences and age-related white matter changes of the human brain: A diffusion tensor imaging study , 2008, NeuroImage.

[62]  A Hofman,et al.  Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes , 2002, Neurology.

[63]  S. Rose,et al.  Gray and white matter changes in Alzheimer's disease: A diffusion tensor imaging study , 2008, Journal of magnetic resonance imaging : JMRI.

[64]  Osamu Abe,et al.  Diffusion abnormalities of the uncinate fasciculus in Alzheimer’s disease: diffusion tensor tract-specific analysis using a new method to measure the core of the tract , 2008, Neuroradiology.

[65]  A. Kamel,et al.  Address for correspondence , 2000 .

[66]  Mony J. de Leon,et al.  Hypometabolism and Altered Cerebrospinal Fluid Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints , 2008, Biological Psychiatry.

[67]  Yaakov Stern,et al.  Memory performance in healthy elderly without Alzheimer’s disease: effects of time and apolipoprotein-E , 2001, Neurobiology of Aging.

[68]  Y. Stern,et al.  Imaging studies and APOE genotype in persons at risk for Alzheimer’s disease , 1996, Current psychiatry reports.

[69]  John J Sidtis,et al.  Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers , 2005, Neuroreport.

[70]  A. Auchus,et al.  Diffusion Tensor Imaging of Normal-Appearing White Matter in Mild Cognitive Impairment and Early Alzheimer Disease: Preliminary Evidence of Axonal Degeneration in the Temporal Lobe , 2007, American Journal of Neuroradiology.

[71]  Hangyi Jiang,et al.  DtiStudio: Resource program for diffusion tensor computation and fiber bundle tracking , 2006, Comput. Methods Programs Biomed..

[72]  Patrick L. McGeer,et al.  Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.

[73]  C. A. Clark,et al.  A structural equation modeling investigation of age-related variance in executive function and DTI measured white matter damage , 2008, Neurobiology of Aging.

[74]  Edith V. Sullivan,et al.  Frontal circuitry degradation marks healthy adult aging: Evidence from diffusion tensor imaging , 2005, NeuroImage.

[75]  Stian Lydersen,et al.  APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway , 2008, BMC neurology.

[76]  R. Green,et al.  Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial , 2007, Neurology.

[77]  Carole Dufouil,et al.  No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. , 2005, NeuroImage.

[78]  Denis Le Bihan,et al.  Looking into the functional architecture of the brain with diffusion MRI , 2003, Nature Reviews Neuroscience.

[79]  C. Jack,et al.  DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment , 2005, Neurology.

[80]  Paul M. Thompson,et al.  Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: Tract-based spatial statistics study of aging , 2007, NeuroImage.

[81]  S. Ludwin.  The Pathobiology of the Oligodendrocyte , 1997, Journal of neuropathology and experimental neurology.

[82]  C. Jack,et al.  Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. , 2001, Radiology.

[83]  C. Reynolds,et al.  Wechsler memory scale-revised , 1988 .

[84]  M. Filippi,et al.  White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.

[85]  Amy J. Jak,et al.  Differential Cross-Sectional and Longitudinal Impact of APOE Genotype on Hippocampal Volumes in Nondemented Older Adults , 2007, Dementia and Geriatric Cognitive Disorders.

[86]  Harald Hampel,et al.  Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study. , 2007, Cerebral cortex.

[87]  L Nyberg,et al.  Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? , 2006, Neurology.

[88]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.

[89]  Anders H. Andersen,et al.  White matter diffusion alterations in normal women at risk of Alzheimer's disease , 2010, Neurobiology of Aging.

[90]  Christian Beaulieu,et al.  Diffusion anisotropy in subcortical white matter and cortical gray matter: Changes with aging and the role of CSF‐suppression , 2004, Journal of magnetic resonance imaging : JMRI.

[91]  Peter Stoeter,et al.  Functional implications of hippocampal volume and diffusivity in mild cognitive impairment , 2005, NeuroImage.

[92]  Karen M Rodrigue,et al.  Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension. , 2009, Neuropsychology.

[93]  S. Goodman,et al.  Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic Review , 2004, Neuroepidemiology.

[94]  E. Boerwinkle,et al.  APOE genotype and cognitive decline in a middle-aged cohort , 2005, Neurology.

[95]  Maria Assunta Rocca,et al.  Voxel-based analysis derived from fractional anisotropy images of white matter volume changes with aging , 2008, NeuroImage.

[96]  Matthias J. Müller,et al.  Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus , 2006, Psychiatry Research: Neuroimaging.

[97]  G. Vogler,et al.  Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world , 1992, Genetic epidemiology.

[98]  John T. O'Brien,et al.  Atrophy is associated with posterior cingulate white matter disruption in dementia with Lewy bodies and Alzheimer’s disease , 2007, NeuroImage.

[99]  Alan Peters,et al.  The Effects of Normal Aging on Myelinated Nerve Fibers in Monkey Central Nervous System , 2009, Front. Neuroanat..

[100]  D. Neary,et al.  Apolipoprotein E ε4 Allele Frequency and Age at Onset of Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.

[101]  D. Crockett.  A comparison of empirically derived groups of aphasic patients on the Neurosensory Center Comprehensive Examination for Aphasia. , 1977, Journal of clinical psychology.

[102]  A. Pfefferbaum,et al.  Diffusion tensor imaging and aging , 2006, Neuroscience & Biobehavioral Reviews.

[103]  J. Kwentus,et al.  Modified wisconsin sorting test in elderly normal, depressed and demented patients , 1988 .

[104]  D. Bennett,et al.  White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study , 2006, Neurobiology of Aging.

[105]  K. Davis,et al.  Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. , 2003, JAMA.

[106]  D. Head,et al.  Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. , 2004, Cerebral cortex.

[107]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[108]  J. M. Guralnik,et al.  The role of APOE-&egr;4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging , 2003 .

[109]  S. Sakoda,et al.  Apolipoprotein E epsilon 4. , 1994, Neurology.

[110]  E. Glisky,et al.  Source memory in older adults: an encoding or retrieval problem? , 2001 .

[111]  N. Schuff,et al.  Headache and cerebral venous air embolism , 2007, Neurology.

[112]  E. Glisky,et al.  Do young and older adults rely on different processes in source memory tasks? A neuropsychological study. , 2008, Journal of experimental psychology. Learning, memory, and cognition.

[113]  A. Peters.  The effects of normal aging on myelin and nerve fibers: A review , 2002, Journal of neurocytology.

[114]  L. J. Whalley,et al.  White matter integrity and cognition in childhood and old age , 2006, Neurology.

[115]  Jing Zhang,et al.  Age-related changes of normal adult brain structure: analysed with diffusion tensor imaging. , 2005, Chinese medical journal.

[116]  R. Mahley,et al.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[117]  Lars Bäckman,et al.  Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. , 2005, Neuropsychology.

[118]  Hiromu Nishitani,et al.  Regional changes of fractional anisotropy with normal aging using statistical parametric mapping (SPM). , 2005, The journal of medical investigation : JMI.